Use of anti-sphingosine-1-phosphate antibodies in combination with chemotherapeutic agents
US8361465B2 · kind B2 · utility
0Cited by
103References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 19, 2010 |
| Grant date | Jan 29, 2013 |
| Priority date | — |
| Expiry date | Jan 19, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to use of anti-S1P antibodies in combination with chemotherapeutic agents for treatment and/or prevention of cancer, tumor growth, metastasis and/or growth of metastatic tumors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.